Atlas Trials

COVID-19 Vaccine Biomarker Study in Multiple Sclerosis

Clinical trial NCT05121662 · COMPLETED

Trial details

NCT number
NCT05121662
Sponsor
Columbia University
Status
COMPLETED
Study type
OBSERVATIONAL
Multiple SclerosisCOVID-19
Start date
2021-07-29
Primary completion
2025-02-13
Enrollment
154

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.